216 related articles for article (PubMed ID: 14526312)
1. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.
Chandra S; Scott H; Dodds L; Watts C; Blight C; Van Den Hof M
Am J Obstet Gynecol; 2003 Sep; 189(3):775-81. PubMed ID: 14526312
[TBL] [Abstract][Full Text] [Related]
2. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
3. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
4. Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome.
Onderoğlu LS; Kabukçu A
Int J Gynaecol Obstet; 1997 Mar; 56(3):245-9. PubMed ID: 9127156
[TBL] [Abstract][Full Text] [Related]
5. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Huerta-Enochian G; Katz V; Erfurth S
Am J Obstet Gynecol; 2001 Jun; 184(7):1549-53; discussion 1553-5. PubMed ID: 11408879
[TBL] [Abstract][Full Text] [Related]
6. Isolated low second-trimester maternal serum beta-human chorionic gonadotropin is not associated with adverse pregnancy outcome.
Endres LK; Krotz S; Grobman WA
Am J Obstet Gynecol; 2003 Sep; 189(3):755-7. PubMed ID: 14526308
[TBL] [Abstract][Full Text] [Related]
7. Unexplained elevations of maternal serum alpha-fetoprotein.
Katz VL; Chescheir NC; Cefalo RC
Obstet Gynecol Surv; 1990 Nov; 45(11):719-26. PubMed ID: 1700347
[TBL] [Abstract][Full Text] [Related]
8. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
9. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
10. Labor induction versus expectant management at early term in pregnancies with second trimester elevated human chorionic gonadotropin or alpha fetoprotein.
Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
J Obstet Gynaecol Res; 2018 Jun; 44(6):1049-1056. PubMed ID: 29516643
[TBL] [Abstract][Full Text] [Related]
11. Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening.
Cho S; Durfee KK; Keel BA; Parks LH
J Perinat Med; 1997; 25(6):476-83. PubMed ID: 9494919
[TBL] [Abstract][Full Text] [Related]
12. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.
Wenstrom KD; Owen J; Boots LR; DuBard MB
Am J Obstet Gynecol; 1994 Oct; 171(4):1038-41. PubMed ID: 7524322
[TBL] [Abstract][Full Text] [Related]
13. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
[TBL] [Abstract][Full Text] [Related]
14. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
15. Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening.
van Rijn M; van der Schouw YT; Hagenaars AM; Visser GH; Christiaens GC
Obstet Gynecol; 1999 Dec; 94(6):929-34. PubMed ID: 10576178
[TBL] [Abstract][Full Text] [Related]
16. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
[TBL] [Abstract][Full Text] [Related]
17. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of elevated anticardiolipin antibodies in pregnant women with unexplained elevations of alpha-fetoprotein.
Yetman DL; Kutteh WH; Castorena R; Brown C; Baskin L
J Reprod Immunol; 1997 Apr; 33(1):71-81. PubMed ID: 9185078
[TBL] [Abstract][Full Text] [Related]
20. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
